Einloggen
Einloggen
Oder einloggen mit
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registrieren
Oder einloggen mit
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

CHIMERIX, INC.

(A1T65B)
  Bericht
Verzögert Nasdaq  -  22:00 02.12.2022
2.250 USD   -4.26%
11.11.Chimerix lehnt die Forderung des Aktionärs Rubric Capital Management nach Liquidation ab
MT
10.11.Rubric Capital Management schickt Brief an Chimerix
CI
03.11.Transcript : Chimerix, Inc., Q3 2022 Earnings Call, Nov 03, 2022
CI
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivateFonds 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über CHIMERIX, INC.
11.11.Chimerix Rejects Shareholder Rubric Capital Management's Call for Liquidation
10.11.Chimerix Responds to Rubric Capital Management
10.11.Rubric Capital Management Sends Letter to Chimerix
10.11.Rubric Capital Management Sends Letter to Chimerix Board of Directors
03.11.CHIMERIX INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS O..
03.11.Chimerix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Sep..
03.11.Chimerix : Q3 Earnings Snapshot
03.11.Earnings Flash (CMRX) CHIMERIX Reports Q3 Revenue $32.6M
03.11.Chimerix Inc : Results of Operations and Financial Condition, Regulation FD Disclosure, Fi..
03.11.Chimerix Reports Third Quarter 2022 Financial Results and Provides Operational Update
27.10.Chimerix to Report Third Quarter 2022 Financial Results and Provide an Operational Upda..
18.10.Smallpox Pipeline Analysis : 04+ Companies are Working to Improve the Treatment Space | De..
28.09.Chimerix : UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS - Form 8-K
28.09.Chimerix Inc : Entry into a Material Definitive Agreement, Completion of Acquisition or Di..
27.09.Emergent BioSolutions Completes Acquisition of Exclusive Worldwide Rights to TEMBEXA, t..
26.09.Emergent BioSolutions Completes Acquisition of Rights to Smallpox Oral Antiviral Tembex..
26.09.Chimerix Announces Closing of TEMBEXA Sale to Emergent BioSolutions
26.09.Emergent BioSolutions Inc. completed the acquisition of Exclusive Worldwide Rights to B..
06.09.Chimerix to Present at H.C. Wainwright 24th Annual Global Investment Conference
31.08.Chimerix Inc : Entry into a Material Definitive Agreement (form 8-K)
31.08.Testing, Treatment, and Vaccines are the Three Ways Companies Can Fight Monkeypox (SKHH..
29.08.Chimerix Chief Business Officer Michael Andriole Executes Purchase of 50,000 Shares
29.08.Sector Update: Health Care Stocks Moderately Lower in Late Trade
29.08.Sector Update: Health Care
29.08.Chimerix Gets Up to $680 Million US Government Contract for Tembexa Smallpox Treatment;..
29.08.Chimerix Awarded BARDA Contract for TEMBEXA as Medical Countermeasure for Smallpox
29.08.Chimerix Wins BARDA Contract for TEMBEXA as Medical Countermeasure for Smallpox
29.08.Chimerix Shares Jump After Smallpox Drug Supply Deal
09.08.Chimerix : Reports Second Quarter 2022 Financial Results and Provides Operational Update -..
08.08.CHIMERIX INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS O..
08.08.Chimerix : Q2 Earnings Snapshot
08.08.Earnings Flash (CMRX) CHIMERIX Posts Q2 Revenue $440,000
08.08.Chimerix Reports Second Quarter 2022 Financial Results and Provides Operational Update
08.08.Chimerix, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended Jun..
08.08.Chimerix Appoints Christopher L. Jordan as Vice President, Regulatory Affairs
08.08.North American Morning Briefing: Stock Futures -2-
02.08.Chimerix to Present at Wedbush PacGrow Healthcare Conference
01.08.Chimerix to Report Second Quarter 2022 Financial Results and Provide an Operational Upd..
01.08.Chimerix : Material Event - Form 8-K
01.08.Chimerix Inc : Other Events (form 8-K)
25.07.SIGA Technologies, Chimerix Shares Soar After WHO Labels Monkeypox a Global Health Emer..
25.07.Top Premarket Gainers
28.06.Chimerix, Inc. Enters into A Supply Agreement with A Third Party Outside of North Ameri..
28.06.Chimerix Inc : Other Events (form 8-K)
28.06.Chimerix Inc : Submission of Matters to a Vote of Security Holders (form 8-K)
27.06.Chimerix Announces TEMBEXA Procurement Agreement for Approximately $25.3 Million with P..
24.06.Sector Update: Health Care Stocks Carried Higher in Friday Trade
24.06.Sector Update: Health Care
24.06.Chimerix Gets $25.3 Million Contract to Supply Tembexa Smallpox Treatment to Canada; Sh..
24.06.Chimerix gets up to $25.3 mln contract from Canada for smallpox drug
24.06.Chimerix Announces TEMBEXA Procurement Agreement for Approximately $25.3 Million with P..
24.06.Chimerix Announces TEMBEXA Procurement Agreement for Approximately $25.3 Million with P..
23.06.Chimerix Gets $9.3 Million Contract to Supply Tembexa Smallpox Treatment; Shares Rise
23.06.Chimerix Announces $9.3 Million International TEMBEXA Procurement Agreement
23.06.Chimerix Announces $9.3 Million International TEMBEXA Procurement Agreement
23.06.Smallpox drugmakers get new orders as monkeypox spreads
21.06.Chimerix, Inc.(NasdaqGM:CMRX) dropped from S&P Biotechnology Sel..
06.06.Topnewsguide : Healthcare Companies Poised to Pop (WHSI, TNXP, SIGA, CMRX, GOVX)
01.06.Chimerix to Present at Jefferies Global Healthcare Conference
25.05.What vaccines, treatments do we have to combat monkeypox?
23.05.Emergent Biosolutions Shares Rise Further Monday as Countries Report Monkeypox Cases
18.05.Chimerix Signs Asset Purchase Agreement for Brincidofovir; Set to Receive $225 Million ..
18.05.Chimerix Inc : Entry into a Material Definitive Agreement, Financial Statements and Exhibi..
17.05.Chimerix to Present at H.C. Wainwright Global Investment Conference
17.05.Emergent BioSolutions to Acquire from Chimerix its Exclusive Worldwide Rights to TEMBEX..
16.05.Sector Update: Health Care Stocks Strengthen Near Monday Close
16.05.Chimerix Sells Exclusive Rights to Smallpox Treatment Tembexa to Emergent BioSolutions ..
16.05.Top Midday Decliners
16.05.Sector Update: Health Care Stocks Firming on Monday
16.05.Wall Street Wavers Pre-Bell as Weak China Data Dent Sentiment
16.05.Sector Update: Health Care Stocks Edge Higher Pre-Bell Monday
16.05.Sector Update: Health Care
16.05.Top Premarket Decliners
16.05.CHIMERIX INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS O..
16.05.Chimerix Inc : Results of Operations and Financial Condition, Regulation FD Disclosure, Fi..
16.05.Chimerix Sells Exclusive Rights to Smallpox Treatment Tembexa to Emergent BioSolutions ..
16.05.Chimerix : Q1 Earnings Snapshot
16.05.Earnings Flash (CMRX) CHIMERIX Reports Q1 Revenue $15,000
16.05.Chimerix Reports First Quarter 2022 Financial Results and Provides Operational Update
16.05.Chimerix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
16.05.Chimerix Announces Sale of TEMBEXA to Emergent BioSolutions for up to $337.5 Million pl..
16.05.North American Morning Briefing: Stock Futures -3-
16.05.Emergent BioSolutions Inc. entered into an agreement to acquire Exclusive Worldwide Rig..
12.05.Chimerix to Participate in Maxim Group Panel Discussion
09.05.Chimerix to Report First Quarter 2022 Financial Results and Provide an Operational Upda..
18.04.Chimerix Inc : Change in Directors or Principal Officers, Financial Statements and Exhibit..
13.04.Chimerix : Regulation FD Disclosure - Form 8-K
13.04.Chimerix Inc : Regulation FD Disclosure (form 8-K)
24.03.Chimerix : International Conference on Antiviral Research 2022 Presentation
21.03.Chimerix to Present at Maxim Group 2022 Virtual Growth Conference
01.03.CHIMERIX INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS O..
01.03.Chimerix : Q4 Earnings Snapshot
01.03.Chimerix : Reports Fourth Quarter and Year End 2021 Financial Results and Provides Operati..
01.03.Chimerix, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021
01.03.Chimerix Reports Fourth Quarter and Year End 2021 Financial Results and Provides Operat..
01.03.Chimerix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
28.02.Chimerix to Present at Cowen and Company 42nd Annual Health Care Conference
25.02.Chimerix, in Collaboration with the Rapidly Emerging Antiviral Drug Development Initiat..
24.02.Chimerix, in Collaboration with the Rapidly Emerging Antiviral Drug Development Initiat..
24.02.Chimerix, in Collaboration with the Rapidly Emerging Antiviral Drug Development Initiat..